Short description
Bioasis Technologies, Inc. is a biopharmaceutical company.
Description
Bioasis Technologies Inc. is a biopharmaceutical company developing the xB3 ™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The delivery of therapeutics across the blood brain barrier represents the final frontier in treating neurological disorders. The in-house development programs at Bioasis are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Richmond, British Columbia, Canada, North America
Founded on
January 1, 2007
Exited on
July 27, 2007
Went public on
July 27, 2007
Stock symbol
BTI
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$34056 - 789030
Sign in for full access
Investors
Blurry Noaccess
Sign in for full access
Founders
Rob Hutchison